Though we found an increased event rate with low HR positivity compared with TNBC with <1% ER/PR disease in RFS only, the magnitude of these event rates was still relatively low compared with historical event rates for HR+ disease; a similar trend was seen for RFI and DRFS, though as discussed did not reach statistical significance.
← all excerpts
Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity.
1
—
—